Beyond Meat, Inc. (BIT:1BYND)
Italy · Delayed Price · Currency is EUR 2.391
-0.223 (-8.53%)
At close: Aug 7, 2025, 5:30 PM CET
Longboard Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 28, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2020 |
Revenue | 301.35 | 326.45 | 343.38 | 418.93 | 464.7 | 406.79 | Upgrade |
Revenue Growth (YoY) | -5.17% | -4.93% | -18.04% | -9.85% | 14.24% | 36.55% | Upgrade |
Cost of Revenue | 269.51 | 284.75 | 354.73 | 442.68 | 347.42 | 284.51 | Upgrade |
Gross Profit | 31.84 | 41.7 | -11.35 | -23.74 | 117.28 | 122.28 | Upgrade |
Selling, General & Admin | 171.67 | 171.82 | 212.41 | 239.51 | 209.47 | 133.66 | Upgrade |
Research & Development | 16.42 | 18.5 | 29.86 | 62.26 | 66.95 | 31.54 | Upgrade |
Operating Expenses | 188.09 | 190.32 | 242.27 | 301.77 | 276.42 | 165.19 | Upgrade |
Operating Income | -156.25 | -148.62 | -253.62 | -325.51 | -159.14 | -42.92 | Upgrade |
Interest Expense | -5.08 | -4.1 | -3.96 | -3.97 | -3.65 | -2.58 | Upgrade |
Interest & Investment Income | 3.7 | 6 | 10.8 | 4.5 | 0.2 | - | Upgrade |
Earnings From Equity Investments | -0.12 | -0.07 | -3.9 | -18.95 | -2.98 | - | Upgrade |
Currency Exchange Gain (Loss) | 8.2 | -6.3 | 1.1 | -4.9 | -0.2 | 0.2 | Upgrade |
Other Non Operating Income (Expenses) | -0.46 | 0.29 | -0.28 | -0.02 | 0.55 | 0.58 | Upgrade |
EBT Excluding Unusual Items | -150.01 | -152.8 | -249.86 | -348.85 | -165.21 | -44.71 | Upgrade |
Merger & Restructuring Charges | - | - | -83.88 | -17.26 | -15.79 | -6.43 | Upgrade |
Legal Settlements | -7.5 | -7.5 | - | - | - | - | Upgrade |
Other Unusual Items | - | - | -4.4 | - | -1.04 | -1.54 | Upgrade |
Pretax Income | -157.51 | -160.3 | -338.14 | -366.11 | -182.05 | -52.68 | Upgrade |
Income Tax Expense | 0.01 | -0.03 | 0.01 | 0.03 | 0.06 | 0.07 | Upgrade |
Net Income | -157.52 | -160.28 | -338.14 | -366.14 | -182.11 | -52.75 | Upgrade |
Net Income to Common | -157.52 | -160.28 | -338.14 | -366.14 | -182.11 | -52.75 | Upgrade |
Shares Outstanding (Basic) | 72 | 66 | 64 | 64 | 63 | 62 | Upgrade |
Shares Outstanding (Diluted) | 72 | 66 | 64 | 64 | 63 | 62 | Upgrade |
Shares Change (YoY) | 11.04% | 2.65% | 1.06% | 0.71% | 1.42% | 47.35% | Upgrade |
EPS (Basic) | -2.19 | -2.43 | -5.26 | -5.75 | -2.88 | -0.85 | Upgrade |
EPS (Diluted) | -2.20 | -2.43 | -5.26 | -5.75 | -2.88 | -0.85 | Upgrade |
Free Cash Flow | -125.27 | -109.83 | -118.39 | -393.54 | -437.33 | -115.46 | Upgrade |
Free Cash Flow Per Share | -1.75 | -1.66 | -1.84 | -6.19 | -6.92 | -1.85 | Upgrade |
Gross Margin | 10.57% | 12.77% | -3.31% | -5.67% | 25.24% | 30.06% | Upgrade |
Operating Margin | -51.85% | -45.53% | -73.86% | -77.70% | -34.25% | -10.55% | Upgrade |
Profit Margin | -52.27% | -49.10% | -98.48% | -87.40% | -39.19% | -12.97% | Upgrade |
Free Cash Flow Margin | -41.57% | -33.64% | -34.48% | -93.94% | -94.11% | -28.38% | Upgrade |
EBITDA | -132.83 | -125.5 | -205.53 | -292.93 | -137.48 | -29.62 | Upgrade |
EBITDA Margin | -44.08% | -38.44% | -59.86% | -69.92% | -29.58% | -7.28% | Upgrade |
D&A For EBITDA | 23.42 | 23.12 | 48.09 | 32.58 | 21.66 | 13.3 | Upgrade |
EBIT | -156.25 | -148.62 | -253.62 | -325.51 | -159.14 | -42.92 | Upgrade |
EBIT Margin | -51.85% | -45.53% | -73.86% | -77.70% | -34.24% | -10.55% | Upgrade |
Advertising Expenses | - | 8.5 | 17.2 | 20.6 | 12.1 | 0.3 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.